New heart scan could revolutionize how doctors detect and track amyloidosis
NCT ID NCT07218705
Summary
This study is testing a new type of heart scan called magnetocardiography (MCG) to see if it can better detect and monitor amyloidosis, a disease where abnormal proteins build up in organs. Researchers will enroll 500 adults with amyloidosis to compare the new MCG scan against standard electrocardiogram (ECG) tests. The goal is to determine if this non-invasive scan is more accurate at diagnosing the disease and tracking how it changes over time or with treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.